Antimicrobial Regimens Prescribed by Canadian Physicians for Chemotherapy-Induced Febrile Neutropenic Episodes

Affiliations

Michel Laverdière: Department of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada
Eric J Bow: Department of Medicine and Medical Microbiology, Health Sciences Centre, The University of Manitoba and The Manitoba Cancer Treatment and Research Foundation, Winnipeg, Manitoba, Canada
Coleman Rotstein: Division of Infectious Diseases, Department of Medicine, Henderson Site, Hamilton Health Sciences Corporation, McMaster University, Hamilton, Ontario, Canada
Stratis Ioannou: Pharmaceuticals Group, Pfizer Canada, Limited, Pointe-Claire, Québec, Canada
Danielle Carr: Pharmaceuticals Group, Pfizer Canada, Limited, Pointe-Claire, Québec, Canada
Narguess Moghaddam: Pharmaceuticals Group, Pfizer Canada, Limited, Pointe-Claire, Québec, Canada
the Canadian Fluconazole Study Group

Abstract

OBJECTIVE: To study the antimicrobial management of cancer patients with chemotherapy-induced neutropenia by Canadian physicians.

ISSN: 1180-2332 (Print)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/9575